Mustapa Muhammad Adzran Che, Amin Latifah, Frewer Lynn J
Pusat Citra Universiti, Universiti Kebangsaan Malaysia, 43600 UKM, Bangi, Selangor, Malaysia.
The Institute of Islam Hadhari, Universiti Kebangsaan Malaysia, 43600 UKM, Bangi, Selangor, Malaysia.
Genes Nutr. 2020 Sep 22;15(1):16. doi: 10.1186/s12263-020-00676-y.
Nutrigenomics is an emerging science that studies the relationship between genes, diet and nutrients that can help prevent chronic disease. The development of this science depends on whether the public accept its application; therefore, predicting their intention to adopt it is important for its successful implementation.
This study aims to analyse Malaysian stakeholders' intentions to adopt nutrigenomics, and determines the factors that influence their intentions.
A survey was conducted based on the responses of 421 adults (aged 18 years and older) and comprising two stakeholder groups: healthcare providers (n = 221) and patients (n = 200) who were located in the Klang Valley, Malaysia. The SPSS software was used to analyse the descriptive statistics of intention to adopt nutrigenomics and the SmartPLS software was used to determine the predicting factors affecting their decisions to adopt nutrigenomics.
The results show that the stakeholders perceived the benefits of nutrigenomics as outweighing its risks, suggesting that the perceived benefits represent the most important direct predictor of the intention to adopt nutrigenomics. The perceived risks of nutrigenomics, trust in key players, engagement with medical genetics and religiosity also predict the intention to adopt nutrigenomics. Additionally, the perceived benefits of nutrigenomics served as a mediator for four factors: perceived risks of nutrigenomics, engagement with medical genetics, trust in key players and religiosity, whilst the perceived risks were a mediator for engagement with medical genetics.
The findings of this study suggest that the intentions of Malaysian stakeholders to adopt nutrigenomics are a complex decision-making process where all the previously mentioned factors interact. Although the results showed that the stakeholders in Malaysia were highly positive towards nutrigenomics, they were also cautious about adopting it.
营养基因组学是一门新兴科学，研究基因、饮食和营养之间的关系，有助于预防慢性病。这门科学的发展取决于公众是否接受其应用；因此，预测他们采用它的意愿对于其成功实施至关重要。
本研究旨在分析马来西亚利益相关者采用营养基因组学的意愿，并确定影响其意愿的因素。
基于421名成年人（18岁及以上）的回答进行了一项调查，包括两个利益相关者群体：位于马来西亚巴生谷的医疗保健提供者（n = 221）和患者（n = 200）。使用SPSS软件分析采用营养基因组学意愿的描述性统计数据，并使用SmartPLS软件确定影响他们采用营养基因组学决策的预测因素。
结果表明，利益相关者认为营养基因组学的益处大于风险，这表明感知到的益处是采用营养基因组学意愿的最重要直接预测因素。营养基因组学的感知风险、对关键参与者的信任、与医学遗传学的接触以及宗教信仰也预测了采用营养基因组学的意愿。此外，营养基因组学的感知益处充当了四个因素的中介：营养基因组学的感知风险、与医学遗传学的接触、对关键参与者的信任和宗教信仰，而感知风险是与医学遗传学接触的中介。
本研究结果表明，马来西亚利益相关者采用营养基因组学的意愿是一个复杂的决策过程，所有上述因素相互作用。尽管结果表明马来西亚的利益相关者对营养基因组学高度积极，但他们在采用时也持谨慎态度。
